Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Laura Oliva, Ugo Orfanelli, Massimo Resnati, Andrea Raimondi, Andrea Orsi, Enrico Milan, Giovanni Palladini, Paolo Milani, Fulvia Cerruti, Paolo Cascio, Simona Casarini, Paola Rognoni, Thierry Touvier, Magda Marcatti, Fabio Ciceri, Silvia Mangiacavalli, Alessandro Corso, Giampaolo Merlini, Simone Cenci

Blood (2017) 129 (15): 2132–2142.

https://doi.org/10.1182/blood-2016-08-730978

Published: 2017

Includes: Supplemental data

Journal Articles

Seasonal and pandemic (A/H1N1 2009) MF-59–adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens

Davide Bedognetti, Filippo Ansaldi, Elisa Zanardi, Paolo Durando, Mario Roberto Sertoli, Carlotta Massucco, Enrico Balleari, Omar Racchi, Gabriele Zoppoli, Andrea Orsi, Cristiano Alicino, Giancarlo Icardi, Francesco M. Marincola, Simonetta Zupo, Manlio Ferrarini, Andrea De Maria

Blood (2012) 120 (9): 1954–1957.

https://doi.org/10.1182/blood-2012-06-438689

Published: 2012

Journal Articles

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

Giada Bianchi, Laura Oliva, Paolo Cascio, Niccolò Pengo, Francesca Fontana, Fulvia Cerruti, Andrea Orsi, Elena Pasqualetto, Alexandre Mezghrani, Valeria Calbi, Giovanni Palladini, Nicola Giuliani, Kenneth C. Anderson, Roberto Sitia, Simone Cenci

Blood (2009) 113 (13): 3040–3049.

https://doi.org/10.1182/blood-2008-08-172734

Published: 2009

Includes: Supplemental data

Journal Articles

Proteasome Stress Causes Apoptotic Sensitivity of Multiple Myeloma Cells to Proteasome Inhibition

Giada Bianchi, Laura Oliva, Paolo Cascio, Niccolo’ Pengo, Andrea Orsi, Francesca Fontana, Elena Pasqualetto, Alexandre Mezghrani, Fulvia Cerruti, Valeria Calbi, Giovanni Palladini, Nicola Giuliani, Dharminder Chauhan, Kenneth C. Anderson, Roberto Sitia, Simone Cenci

Blood (2008) 112 (11): 247.

https://doi.org/10.1182/blood.V112.11.247.247

Published: 2008

Journal Articles

Direct Assessment of Proteasomal Degradation as a Potential Predictor of Responsiveness to Bortezomib in Multiple Myeloma.

Giada Bianchi, MD, Andrea Orsi, PhD, Simone Cenci, MD, Paolo Cascio, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD, Roberto Sitia, MD

Blood (2006) 108 (11): 3525.

https://doi.org/10.1182/blood.V108.11.3525.3525

Published: 2006

NARROW

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Seasonal and pandemic (A/H1N1 2009) MF-59–adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

Proteasome Stress Causes Apoptotic Sensitivity of Multiple Myeloma Cells to Proteasome Inhibition

Direct Assessment of Proteasomal Degradation as a Potential Predictor of Responsiveness to Bortezomib in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Seasonal and pandemic (A/H1N1 2009) MF-59–adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

Proteasome Stress Causes Apoptotic Sensitivity of Multiple Myeloma Cells to Proteasome Inhibition

Direct Assessment of Proteasomal Degradation as a Potential Predictor of Responsiveness to Bortezomib in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only